[go: up one dir, main page]

GB202111195D0 - Method for targeted sequencing - Google Patents

Method for targeted sequencing

Info

Publication number
GB202111195D0
GB202111195D0 GBGB2111195.0A GB202111195A GB202111195D0 GB 202111195 D0 GB202111195 D0 GB 202111195D0 GB 202111195 A GB202111195 A GB 202111195A GB 202111195 D0 GB202111195 D0 GB 202111195D0
Authority
GB
United Kingdom
Prior art keywords
targeted sequencing
sequencing
targeted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2111195.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cergentis BV
Original Assignee
Cergentis BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cergentis BV filed Critical Cergentis BV
Priority to GBGB2111195.0A priority Critical patent/GB202111195D0/en
Publication of GB202111195D0 publication Critical patent/GB202111195D0/en
Priority to PCT/EP2022/071758 priority patent/WO2023012193A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1082Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB2111195.0A 2021-08-03 2021-08-03 Method for targeted sequencing Ceased GB202111195D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2111195.0A GB202111195D0 (en) 2021-08-03 2021-08-03 Method for targeted sequencing
PCT/EP2022/071758 WO2023012193A1 (en) 2021-08-03 2022-08-02 Method for targeted sequencing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2111195.0A GB202111195D0 (en) 2021-08-03 2021-08-03 Method for targeted sequencing

Publications (1)

Publication Number Publication Date
GB202111195D0 true GB202111195D0 (en) 2021-09-15

Family

ID=77651387

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2111195.0A Ceased GB202111195D0 (en) 2021-08-03 2021-08-03 Method for targeted sequencing

Country Status (2)

Country Link
GB (1) GB202111195D0 (en)
WO (1) WO2023012193A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1899488T3 (en) 2005-07-04 2015-12-21 Univ Erasmus Medical Ct CHROMOSOM CONFORMATIONS "CAPTURE-ON-CHIP" (4C) -ASSAY
EP2043728A2 (en) 2006-07-11 2009-04-08 Microchips, Inc. Multi-reservoir pump device for dialysis, biosensing, or delivery of substances
GB201320351D0 (en) * 2013-11-18 2014-01-01 Erasmus Universiteit Medisch Ct Method
EP3313992B1 (en) * 2015-06-24 2022-03-23 Dana-Farber Cancer Institute, Inc. Selective degradation of wild-type dna and enrichment of mutant alleles using nuclease
EP3765063A4 (en) * 2018-03-15 2021-12-15 Twinstrand Biosciences, Inc. METHODS AND REAGENTS FOR ENRICHMENT NUCLEIC ACID MATERIAL FOR SEQUENCING APPLICATIONS AND OTHER NUCLEIC ACID MATERIAL INTERROGATIONS
EP3994270A1 (en) * 2019-07-02 2022-05-11 Fred Hutchinson Cancer Research Center Recombinant ad35 vectors and related gene therapy improvements

Also Published As

Publication number Publication date
WO2023012193A1 (en) 2023-02-09

Similar Documents

Publication Publication Date Title
GB202014709D0 (en) Method
GB202010104D0 (en) Method
GB202004944D0 (en) Method
GB202007044D0 (en) Method
GB202102322D0 (en) Method
GB202014432D0 (en) Method
GB202100827D0 (en) Method
GB202015993D0 (en) Method
GB202010922D0 (en) Method
GB202006815D0 (en) Method
GB202004863D0 (en) Method
GB202017861D0 (en) Method
GB202011823D0 (en) Method
GB202111195D0 (en) Method for targeted sequencing
GB202018514D0 (en) Method
GB202018262D0 (en) Method
GB202016334D0 (en) Method
GB202010046D0 (en) Method
GB202006047D0 (en) Method
GB202004515D0 (en) Method
GB202003580D0 (en) Method
GB202104547D0 (en) Sequencing method
GB202019966D0 (en) Sequencing method
GB201907101D0 (en) Sequencing method
GB202101819D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)